Related content

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S.   Cowan D.   Kaski J.-C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1757-1763

Elsevier

Access to resources Recommend Favorite

Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells

By Yin Shi Nan   Liu Min   Jing Dan Qing   Mu Yi Ming   Lu Ju Ming   Pan Chang Yu  

Endocrine Research, Vol. 39, Iss. 2, 2014-05 ,pp. : 67-73

Informa Healthcare

Access to resources Recommend Favorite

Targeting Peroxisome Proliferator-Activated Receptor Gamma for Generation of Antidiabetic Drug

By  

Current Diabetes Reviews, Vol. 9, Iss. 4, 2013-07 ,pp. : 275-285

Bentham Science Publishers

Access to resources Recommend Favorite

Pioglitazone, a Specific Ligand of the Peroxisome Proliferator-Activated Receptor Gamma Reduces Gastric Mucosal Injury Induced by Ischaemia/Reperfusion in Rat

By Konturek P. C.   Brzozowski T.   Kania J.   Kukharsky V.   Bazela K.   Kwiecien S.   Harsch I.   Konturek S. J.   Hahn E. G.  

Scandinavian Journal of Gastroenterology, Vol. 38, Iss. 5, 2003-01 ,pp. : 468-476

Informa Healthcare

Access to resources Recommend Favorite

Tissue-Specific Peroxisome Proliferator Activated Receptor Gamma Expression and Metabolic Effects of Telmisartan

By Zídek Václav  

American Journal of Hypertension, Vol. 26, Iss. 6, 2013-06 ,pp. : 829-835

Oxford University Press

Access to resources Recommend Favorite